Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized trial of Goreisan or Saireito plus complex therapy for lower limb lymphedema after gynecologic cancer surgery
jRCT1041190019Phase 2Suspended
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in lymphedema comparing Goreisan + complex therapy with Saireito + complex therapy (2 arms). Primary endpoint: Calculated limb volume. Started Nov 2019; status: suspended.
02
Drugs
oreongsansaireito
03
Conditions
lymphedema
Beyond the preview
Go deeper on jRCT1041190019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041190019.